Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-25 @ 4:28 AM
NCT ID:
NCT02145520
Eligibility Criteria:
Inclusion Criteria:
Infants 1-18 months of age presenting to Al Saad Pediatric Emergency Center from October 2012 to May 2015 with diagnosis of Bronchiolitis and bronchiolitis clinical severity score \> 4,will be include in the study.
Exclusion Criteria:
* Prematurity (Gestational age 34 weeks or less);
* Previous history of wheezing;
* Use of steroid within 48 hours of presentation;
* CRITICALLY ill patients with one or more of the following:
1. obtunded consciousness
2. progressive respiratory failure requiring intensive care unit (PICU) admission;
3. history of apnea within 24 hours before presentation
4. oxygen saturation \< 85% on room air at the time of recruitment
* History of chronic lung disease;Chronic lung disease of prematurity Cystic fibrosis;
* Congenital heart disease.
* All immunodeficient children: primary or secondary
* Known hypersensitivity to magnesium sulfate.
* Known to have magnesium or calcium metabolism disturbance. (e.g.; vitamin D deficiency, hypoparathyroidism).
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Month
Maximum Age:
18 Months
Study:
NCT02145520
Study Brief:
Protocol Section:
NCT02145520